. 2006 Aug;50(8):2680–2685. doi: 10.1128/AAC.00272-06

TABLE 2.

Cumulative proportions of MRSA isolates (n = 511) inhibited by increasing concentrations of antimicrobial agents^a

Antimicrobial agent	% of strains inhibited at MIC (mg/liter) of:														% of strains per susceptibility category
Antimicrobial agent	0.06	0.12	0.25	0.5	1	2	4	8	16	32	64	128	>128	>1,024	S	I	R
OXA	0	0	0	0	0	0	0	4	9	41	75	86	100		0	0	100
FOX	0	0	0	0	0	0	0	4	24	49	69	79	100		3.7	20.4	75.9
BPR	0	4	30	56	86	99	100	100	100	100	100	100	100		ND	ND	ND
VAN	0	0	1	68	100	100	100	100	100	100	100	100	100		100^b	0	0
TEC	0	0	12	79	96	99	100	100	100	100	100	100	100		100^b	0	0
DAP	0	16	88	100	100	100	100	100	100	100	100	100	100		100	0	0
ERY	4	12	40	41	41	41	41	41	42	44	44	45	100		40.7	0	59.3
CLI	33	58	61	61	61	61	61	61	61	61	61	62	100		61.4	0	38.6
Q-D	0	3	43	94	100	100	100	100	100	100	100	100	100		100	0	0
CIP	0	0	0	1	2	2	3	5	13	20	29	45	100		1.6	0.6	97.8
LZD	0	0	0	1	19	100	100	100	100	100	100	100	100		100	0	0
GEN	0	23	91	95	95	95	95	95	95	96	97	99	100		95.1	0	4.9
TOB	3	28	53	54	55	55	55	56	58	60	62	69	100		54.8	0.8	44.4
KAN	0	0	1	5	44	55	57	58	59	63	72	85	100		59.3	2.9	37.8
AMK	0	0	0	0	33	56	59	84	98	99	100	100	100		97.7	1.4	1.0
MIN	48	83	90	91	92	92	94	96	100	100	100	100	100		94.3	1.6	4.1
TET	0	34	77	89	89	89	90	90	91	93	97	99	100		89.6	0.8	9.6
TIG	1	41	95	100	100	100	100	100	100	100	100	100	100		100	0	0
RIF	96	97	97	97	97	99	99	99	99	99	99	99	100		97.1	1.6	1.4
SXT	99	99	100	100	100	100	100	100	100	100	100	100	100		100	0	0
FUS	46	83	96	96	97	99	99	99	99	99	99	100	100		98.6	0.6	0.8
MUP	15	51	91	93	93	94	94	95	96	96	96	96	96	100	93.5	2.9	3.5

Abbreviations: OXA, oxacillin; FOX, cefoxitin; BPR, ceftobiprole; VAN, vancomycin; TEC, teicoplanin; ERY, erythromycin; CLI, clindamycin; Q-D, quinupristin-dalfopristin; CIP, ciprofloxacin; LZD, linezolid; GEN, gentamicin; TOB, tobramycin; KAN, kanamycin; AMK, amikacin; MIN, minocycline; TET, tetracycline; TIG, tigecycline; DAP, daptomycin; RIF, rifampin; SXT, trimethoprim-sulfamethoxazole; FUS, fusidic acid; MUP, mupirocin; ND, not determined; S, susceptible; I, intermediate; R, resistant.

Including six hetero-GISA isolates.